Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $26.75 USD
Change Today +0.20 / 0.75%
Volume 198.1K
IMS On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

ims health holdings inc (IMS) Snapshot

Open
$26.50
Previous Close
$26.55
Day High
$26.82
Day Low
$26.50
52 Week High
09/16/14 - $28.48
52 Week Low
04/15/14 - $21.63
Market Cap
9.0B
Average Volume 10 Days
383.9K
EPS TTM
$-0.45
Shares Outstanding
335.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMS HEALTH HOLDINGS INC (IMS)

ims health holdings inc (IMS) Related Businessweek News

View More BusinessWeek News

ims health holdings inc (IMS) Details

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, prescriptions, electronic medical records, biomarkers, and government statistics that provide information about treatment patterns, disease progression, therapeutic switching, and concomitant diseases and treatments. In addition, the company offers a range of hosted and cloud-based applications, and associated implementation services; AnalyticsLink, software as a service based analytics solution; and MIDAS, which acts as a source of insight into international market dynamics. Further, it provides clinical solutions that help biopharmaceutical companies and clinical research organizations to design, plan, execute, and track clinical trials, as well as it integrates client data with company’s information and proprietary analytics that enable risk-sharing and pay-for-performance programs, network design and management, and population health management for payers and providers. The company primarily serves life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and financial communities. IMS Health Holdings, Inc. was founded in 1954 and is based in Danbury, Connecticut.

10,200 Employees
Last Reported Date: 02/13/15
Founded in 1954

ims health holdings inc (IMS) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.6M
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $457.5K
Senior Vice President of Global Technology & ...
Total Annual Compensation: $405.9K
Senior Vice President of Global Services
Total Annual Compensation: $426.3K
Senior Vice President of Strategy & Global Pr...
Total Annual Compensation: $410.0K
Compensation as of Fiscal Year 2014.

ims health holdings inc (IMS) Key Developments

IMS Health Holdings, Inc. Announces Executive Appointments, Effective April 1, 2015

IMS Health Holdings, Inc. appointed Kevin Knightly as Senior Vice President, Information Offerings, effective April 1, 2015. Mr. Knightly was previously Senior Vice President, Supplier Management. Robert Chu has been appointed Senior Vice President, Technology Solutions effective April 1, 2015. Mr. Chu is President, IMS Health Asia Pacific and previously was General Manager of IMS France. Earlier in his career, he spent 15 years at IBM Corporation in sales, consulting and technology leadership roles. Also effective April 1, Satwinder Sian, formerly Senior Vice President, Global Technology Operations, has been named strategic advisor to the Chief Executive Officer.

IMS Health Announces Pricing of €275 Million Senior Notes, Due April 1, 2023

IMS Health Holdings, Inc. announced the pricing of its offering of €275 million in gross proceeds of senior notes to be issued by IMS Health Incorporated. The net proceeds from the notes offering will be used to fund a portion of the purchase price for IMS Health’s previously announced proposed acquisition of certain customer relationship management and strategic data businesses of Cegedim, SA and for related fees and expenses. The notes will bear interest at a rate of 4.125% and will pay interest semi-annually in arrears on October 1 and April 1 of each year beginning on October 1, 2015. The notes will mature on April 1, 2023. The notes are being offered only to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933 and outside the United States only to non-U.S. investors pursuant to Regulation S.

IMS Health Incorporated Intends to Raise €275 Million Through an Offering of Senior Notes Due 2023

IMS Health Holdings Inc. announced that its wholly-owned subsidiary, IMS Health Incorporated, intends to raise €275 million in gross proceeds through an offering of senior notes due 2023. The net proceeds from the notes offering will be used to fund a portion of the purchase price for IMS Health’s previously announced proposed acquisition of certain customer relationship management and strategic data businesses of Cegedim, SA and for related fees and expenses. The consummation of the notes offering is subject to market and other conditions. The notes are being offered only to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933 and outside the United States only to non-U.S. investors pursuant to Regulation S.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMS:US $26.75 USD +0.20

IMS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GFK SE €34.15 EUR +0.021
Informatica Corp $43.96 USD +0.07
PAREXEL International Corp $68.38 USD +0.78
Teradata Corp $42.71 USD +0.09
Veeva Systems Inc $25.46 USD +0.11
View Industry Companies
 

Industry Analysis

IMS

Industry Average

Valuation IMS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.8x
Price/Book 4.8x
Price/Cash Flow 16.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMS HEALTH HOLDINGS INC, please visit www.imshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.